Wedge Capital Management
TARS icon

Wedge Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Wedge Capital Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.86M Sell
23,625
-171
-0.7% -$11.9K 0.03% 346
2026
Q2 		$1.5M Buy
23,796
+4,092
+21% +$261K 0.02% 375
2026
Q1 		$1.38M Buy
+19,704
New +$1.38M 0.03% 407

Other funds holding TARS

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.14% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
West Wealth Group
West Wealth Group Irvine, California $645M AUM 17.37% 1-Year Est. Return

Wedge Capital Management's TARS Position: Q3 2026 in Review

Wedge Capital Management reduced its Tarsus Pharmaceuticals (TARS) stake by 0.72% in Q3 2026, selling an estimated $11.9K and leaving 23,625 shares worth $1.86M. The position accounts for 0.03% of the portfolio, ranked #346.

Wedge Capital Management first reported a position in TARS in Q1 2026 and has held it in 3 quarters since. 26 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • Wedge Capital Management held 23,625 shares of Tarsus Pharmaceuticals worth $1.86M as of Q3 2026.
  • Wedge Capital Management sold 171 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $11.9K.
  • Tarsus Pharmaceuticals made up 0.03% of Wedge Capital Management's portfolio in Q3 2026, its #346 holding.
  • Wedge Capital Management first reported a position in Tarsus Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 26 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Wedge Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.